Legislation Details

File #: 7518   
Type: Consent Status: Passed
File created: 2/17/2023 Department: Arrowhead Regional Medical Center
On agenda: 2/28/2023 Final action: 2/28/2023
Subject: Amendment to Agreement with Spectra Laboratories, Inc. for Water Sample Testing
Attachments: 1. ADD - CON-ARMC-2-28-23-Spectra Laboratories Inc.pdf, 2. Item #11 Executed BAI, 3. 21-159-A-1 Executed Contract

REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS

OF SAN BERNARDINO COUNTY

AND RECORD OF ACTION

 

                                          February 28, 2023

 

FROM

WILLIAM L. GILBERT, Director, Arrowhead Regional Medical Center 

         

SUBJECT                      

Title                     

Amendment to Agreement with Spectra Laboratories, Inc. for Water Sample Testing

End

 

RECOMMENDATION(S)

Recommendation

Approve Amendment No. 1 to Agreement No. 21-159 with Spectra Laboratories, Inc. for dialysis machine water sample testing services, to increase the not-to-exceed amount by $60,000, from $60,000 to a total not-to-exceed amount of $120,000, and to extend the term of the contract by two years for a total contract term of March 2, 2021 through March 1, 2025.

(Presenter: William L. Gilbert, Director, 580-6150)

Body

 

COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES

Provide for the Safety, Health and Social Service Needs of County Residents.

 

FINANCIAL IMPACT

Approval of this item will not result in the use of Discretionary General Funding (Net County Cost) as the additional cost of $60,000 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue are included in the Arrowhead Regional Medical Center (ARMC) 2022-23 budget and will be included in future recommended budgets.

 

BACKGROUND INFORMATION

The Amendment with Spectra Laboratories, Inc. (Spectra) will allow ARMC the ability to continue to conduct water sample testing for both the inpatient and outpatient dialysis units facilitating timely results needed to ensure patient safety. During dialysis, patients are exposed to high amounts of water, and it is important to ensure that the water used for dialysis is safe and clean.

 

As mandated by the Centers for Medicare and Medicaid Services, routine water sample testing is required to ensure patient safety. These tests are designed to monitor the effectiveness of the facility’s water treatment system, identify contaminants that may compromise patient care, and comply with federal regulations for dialysis water quality. Water samples are taken on a routine basis to confirm that results are within the acceptable standard.

 

Spectra is the leader in the laboratory services industry and is certified and accredited by the College of American Pathologists, Clinical Laboratory Improvement Amendments and California Clinical Laboratory License. Spectra reports any results that are out of the normal range to the Biomed Department via a phone call. Any equipment above the allowable limit will not be used on patients.

 

On March 2, 2021 (Item No. 12), the Board of Supervisors approved Agreement No. 21-159 with Spectra, including non-standard contract terms, in the not-to-exceed amount of $60,000, for dialysis machine water sample testing, for the period March 2, 2021 through March 1, 2023.

 

Approval of this Amendment will ensure continued compliance with federal regulations for dialysis water quality and provide for the safety and health needs of County residents by ensuring that water used for dialysis at the hospital is safe and clean.

 

PROCUREMENT

This is a continuation of a non-competitive procurement supported by the Purchasing Department based on specialized expertise and training as Spectra is a wholly owned subsidiary of Fresenius Medical Care, which is the manufacturer of ARMC’s dialysis machines. ARMC currently utilizes Spectra for dialysis machine water sample testing services.

 

REVIEW BY OTHERS

This item has been reviewed by County Counsel (Charles Phan, Deputy County Counsel, 387-5465) on January 20, 2023; Purchasing (Ariel Gill, Buyer III, 777-0722) on January 20, 2023; ARMC Finance (Chen Wu, Finance Budget Officer, 580-3165) on February 6, 2023; Finance (Jenny Yang, Administrative Analyst, 387-4884) on February 7, 2023; and County Finance and Administration (Valerie Clay, Deputy Executive Officer, 387-5423) on February 8, 2023.